• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparative serum bactericidal activity against Pseudomonas aeruginosa of six antipseudomonal agents.

作者信息

Dan M, Zabeeda D, Poch F

机构信息

Infectious Disease Unit, E. Wolfson Hospital, Holon, Israel.

出版信息

Chemotherapy. 1995 Sep-Oct;41(5):323-9. doi: 10.1159/000239362.

DOI:10.1159/000239362
PMID:8521732
Abstract

Serum levels and serum bactericidal activities of six antipseudomonal agents were studied comparatively in 60 patients. Single intravenous doses of gentamicin (1.5 mg/kg), piperacillin (4 g), ceftazidime (1 g), imipenem (0.5 g), aztreonam (1 g), and ciprofloxacin (200 mg) were given over 30 min to 10 patients each, and serum samples were obtained 30 min, 1, 2, 3, 4, 6, 8 and 12 h after beginning the infusion. Serum bactericidal activity was determined by the broth microdilution method against 10 recent isolates of Pseudomonas aeruginosa. Mean peak serum levels were as follows: gentamicin 10.4 micrograms/ml, piperacillin 227.5 micrograms/ml, ceftazidime 43.5 micrograms/ml, imipenem 17.3 micrograms/ml, aztreonam 42.3 micrograms/ml, and ciprofloxacin 3.9 micrograms/ml. All agents demonstrated effective serum bactericidal activity (geometric mean titer > 1:2) at peak serum levels. Ceftazidime was by far the most potent compound with a mean titer of 1:46.5, followed by ciprofloxacin (1:17), imipenem (1:13.7), and aztreonam (1:13.4). Ceftazidime also showed the longest duration of activity with a mean titer of 1:5.1 at 4 h. Based on our results, ceftazidime appeared to be the most potent antipseudomonal agent, while gentamicin and piperacillin were the least effective.

摘要

相似文献

1
Comparative serum bactericidal activity against Pseudomonas aeruginosa of six antipseudomonal agents.
Chemotherapy. 1995 Sep-Oct;41(5):323-9. doi: 10.1159/000239362.
2
Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa.亚胺培南与其他五种抗铜绿假单胞菌药物对庆大霉素敏感和耐药铜绿假单胞菌的比较。
Chemotherapy. 1995 Sep-Oct;41(5):334-6. doi: 10.1159/000239364.
3
Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.
Eur J Clin Microbiol. 1986 Feb;5(1):119-23. doi: 10.1007/BF02013481.
4
Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.氧氟沙星和环丙沙星单独及与头孢他啶和哌拉西林联合使用对铜绿假单胞菌临床菌株的杀菌活性比较。
Antimicrob Agents Chemother. 1995 Nov;39(11):2503-10. doi: 10.1128/AAC.39.11.2503.
5
Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.铜绿假单胞菌:在有和没有去纤维蛋白人血的情况下,对单一及联合抗菌药物的体外敏感性
Chemotherapy. 1988;34(4):284-97. doi: 10.1159/000238582.
6
Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.头孢匹罗、头孢他啶、头孢曲松、亚胺培南及环丙沙星的药代动力学与血清杀菌活性的对比研究
Antimicrob Agents Chemother. 1992 Oct;36(10):2085-92. doi: 10.1128/AAC.36.10.2085.
7
The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro.
J Antimicrob Chemother. 1996 Nov;38(5):853-8. doi: 10.1093/jac/38.5.853.
8
[Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].[铜绿假单胞菌对氨曲南与其他抗假单胞菌β-内酰胺类抗生素及庆大霉素的敏感性比较]
Arzneimittelforschung. 1985;35(8):1322-5.
9
Ciprofloxacin: a comparative evaluation of its bactericidal activity in human serum against four enterobacterial species.环丙沙星:对其在人血清中针对四种肠杆菌属细菌的杀菌活性的比较评估。
Drugs Exp Clin Res. 1986;12(11):889-94.
10
[Activities of antipseudomonal agents against clinical isolates of Pseudomonas aeruginosa].
Jpn J Antibiot. 1995 Oct;48(10):1581-9.